Optical Coherence Tomography
Cross-source consensus on Optical Coherence Tomography from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Other
Other
Highlighted claims
- OCT is used in REPRESS because it provides high-resolution intravascular imaging of plaque morphology. — PCSK9 inhibitoRs for Early Passivation of coRonary athEroSclerotic plaqueS in acute coronary syndromes (REPRESS): study protocol for a multicentre randomised controlled trial
- Serial OCT imaging is performed at baseline and 6 months in non-culprit coronary arteries with 20-70% stenosis. — PCSK9 inhibitoRs for Early Passivation of coRonary athEroSclerotic plaqueS in acute coronary syndromes (REPRESS): study protocol for a multicentre randomised controlled trial
- OCT images and angiograms are analysed offline by trained core laboratory specialists blinded to treatment allocation and imaging timepoint. — PCSK9 inhibitoRs for Early Passivation of coRonary athEroSclerotic plaqueS in acute coronary syndromes (REPRESS): study protocol for a multicentre randomised controlled trial
- REPRESS defines vulnerable plaque by fibrous cap thickness below 75 µm plus at least two additional high-risk features. — PCSK9 inhibitoRs for Early Passivation of coRonary athEroSclerotic plaqueS in acute coronary syndromes (REPRESS): study protocol for a multicentre randomised controlled trial
- OCT can characterise fibrous, calcified, lipid-rich, and vulnerable plaque features including cap thickness and macrophage infiltration. — PCSK9 inhibitoRs for Early Passivation of coRonary athEroSclerotic plaqueS in acute coronary syndromes (REPRESS): study protocol for a multicentre randomised controlled trial